Subscriber Content Preview | Request a free trialSearch  

Entries tagged "Takeda Pharmaceutical Co. Ltd."

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Takeda Pharmaceutical Co. Ltd.."

11 result(s) displayed (1 - 11 of 11)

Affymax reviews options including bankruptcy after recall

The company's first and only approved drug, anemia treatment Omontys, is linked to three deaths. Continue reading

Posted on March 19, 2013 1:40 PM

Takeda to sell generics biz from URL deal

The Japanese pharma company will unload the asset to a subsidiary of Mumbai-based generics giant Sun Pharmaceutical for an undisclosed sum. Continue reading

Posted on December 18, 2012 2:39 PM

Deal diary: May 7, 2012

Healthcare's rainmakers had a busy month as an M&A frenzy broke out in their sector. Continue reading

Posted on May 4, 2012 1:08 PM

Nordic Capital consortium completes Nycomed exit

The buyout firms sell Fougera to Novartis for $1.53 billion after spinning the U.S. business off from Nycomed when they sold the larger company to Takeda last year. Continue reading

Posted on May 3, 2012 2:11 PM

Warner Chilcott admits takeover talk

Discussions with potential bidders are at a preliminary stage, says the Irish drugmaker, which is 30.6% owned by THL, Bain Capital and CCMP Capital Advisors Continue reading

Posted on April 30, 2012 3:15 PM

Other noteworthy PE exits

The Private Equity Deals of the Year takes a look at Connection Education, Global Tel*Link, Arcos Dorados and others. Continue reading

Posted on April 13, 2012 3:30 PM

Movers & shakers: Japan

Read a round-up of some of Japan's most active dealmakers, including Takeda Pharmaceutical's Yasuchika Hasegawa, DC Advisory's Tosh Kojima, Simpson Thacher's David Sneider and others. Continue reading

Posted on March 30, 2012 12:00 PM

M&A Deals of the Year: Amgen-BioVex

The pharma strikes a solid deal for what could be a revolutionary cancer drug. Continue reading

Posted on January 20, 2012 12:00 PM

Sanofi makes acquisition in India

French drugmaker Sanofi-Aventis SA has become the latest Big Pharma entity to strike in India, using subsidiary Aventis Pharma Ltd. to grab a division of Mumbai's Universal Medicare Private Ltd.Aventis Pharma, an India-based entity in which Sanofi owns a 60.4%... Continue reading

Posted on August 24, 2011 2:46 PM

Biotech, pharma dealmaking up in 2011

M&A in the biotechnology and pharmaceutical industries is shaping up to rebound in 2011, a new report indicates, given momentum by deals such as the $20.1 billion biotech buyout of Genzyme Corp. by French pharmaceutical giant Sanofi-Aventis SA in February... Continue reading

Posted on August 16, 2011 4:31 PM

Deal doctors without borders

In the first quarter, pharma and medtech cross-border deals numbered seventh in value among the top 15 sectors, and healthcare M&A looks set to continue its strong run. Continue reading

Posted on June 29, 2011 3:33 PM

Movable Type search results powered by Fast Search

Popular tags

Movers & Shakers

Launch Movers and shakers slideshow

Bank of America Merrill Lynch's head of Asia Pacific global markets, Boon Chye Loh, is leaving the bank. For other updates launch today's Movers & shakers slideshow.


Talking private equity trends with Alvarez & Marsal

Low interest rates and alternative financing sources are just two of the many things affecting private equity deals right now, according to Paul Aversano, managing director at Alvarez & Marsal LLC. In a recent studio interview, Aversano discussed the conditions both buyers and sellers are facing at this time. Aversano, who is also the global practice leader for the firm's transaction advisory group, also outlined how low interest rates will continue to affect the M&A market and the pressure that PE firms are feeling to transact. More video